Western blot examination revealed that the aberrant development of p-NF-κB-p65 and MyD88 proteins by 5-FU was considerably suppressed by BO treatment (P < 0.001 compared to 5-FU) (Figure 4F). The gene discussed is NFKB1; the disease is bronchiolitis obliterans syndrome.